AFT Pharmaceuticals Limited (AFP.AX)
AUD 2.45
(4.7%)
AUD 2.45
(4.7%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 15.6 Million NZD | 46.51% |
| 2023 | 10.65 Million NZD | -46.32% |
| 2022 | 19.84 Million NZD | 155.05% |
| 2021 | 7.78 Million NZD | -38.69% |
| 2020 | 12.69 Million NZD | 477.51% |
| 2019 | -3.36 Million NZD | 75.31% |
| 2018 | -13.61 Million NZD | 25.94% |
| 2017 | -18.38 Million NZD | -38.6% |
| 2016 | -13.26 Million NZD | -3.06% |
| 2015 | -12.87 Million NZD | -1056.6% |
| 2014 | -1.11 Million NZD | -747.09% |
| 2013 | 172 Thousand NZD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 1.81 Million NZD | -80.06% |
| 2024 Q4 | 13.79 Million NZD | 659.53% |
| 2024 FY | 15.6 Million NZD | 46.51% |
| 2023 Q2 | 1.54 Million NZD | -90.09% |
| 2023 FY | 10.65 Million NZD | -46.32% |
| 2023 Q4 | 9.1 Million NZD | 489.13% |
| 2022 Q4 | 15.6 Million NZD | 267.78% |
| 2022 FY | 19.84 Million NZD | 155.05% |
| 2022 Q2 | 4.24 Million NZD | -33.72% |
| 2021 Q2 | 1.19 Million NZD | -33.48% |
| 2021 FY | 7.78 Million NZD | -38.69% |
| 2021 Q4 | 6.4 Million NZD | 437.08% |
| 2020 Q4 | 1.79 Million NZD | -81.91% |
| 2020 FY | 12.69 Million NZD | 477.51% |
| 2020 Q2 | 9.9 Million NZD | 1099.27% |
| 2019 Q2 | -4.18 Million NZD | 37.92% |
| 2019 FY | -3.36 Million NZD | 75.31% |
| 2019 Q4 | 826 Thousand NZD | 119.72% |
| 2018 FY | -13.61 Million NZD | 25.94% |
| 2018 Q4 | -6.74 Million NZD | 1.85% |
| 2018 Q2 | -6.87 Million NZD | 6.97% |
| 2017 Q2 | -11 Million NZD | -47.16% |
| 2017 Q4 | -7.38 Million NZD | 32.84% |
| 2017 FY | -18.38 Million NZD | -38.6% |
| 2016 Q2 | -5.79 Million NZD | 14.33% |
| 2016 FY | -13.26 Million NZD | -3.06% |
| 2016 Q4 | -7.47 Million NZD | -29.06% |
| 2015 Q4 | -6.76 Million NZD | -10.62% |
| 2015 FY | -12.87 Million NZD | -1056.6% |
| 2015 Q2 | -6.11 Million NZD | 0.0% |
| 2014 FY | -1.11 Million NZD | -747.09% |
| 2013 FY | 172 Thousand NZD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Althea Group Holdings Limited | -32.05 Million AUD | 148.691% |
| Cann Group Limited | -51.24 Million AUD | 130.461% |
| ECS Botanics Holdings Ltd | 1.91 Million AUD | -714.851% |
| Ecofibre Limited | -44.34 Million AUD | 135.2% |
| Elixinol Wellness Limited | -7.5 Million AUD | 307.926% |
| Hygrovest Limited | -131 Thousand AUD | 12015.267% |
| IDT Australia Limited | -5.41 Million AUD | 388.361% |
| Invion Limited | -5.62 Million AUD | 377.357% |
| Little Green Pharma Ltd | -9.2 Million AUD | 269.563% |
| Live Verdure Ltd | -12.9 Million AUD | 220.927% |
| Medical Developments International Limited | -40.99 Million AUD | 138.078% |
| Vitura Health Limited | 3.51 Million AUD | -344.4% |
| Vita Life Sciences Limited | 9.08 Million AUD | -71.905% |